Skip to main content

Table 4 Variables predicting ≥ 50% response and ≥ 75% response in patients with high frequency episodic migraine (HFEM): A logistic regression model

From: Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients

 

 50% response rate

 75% response rate

Variable

Odds ratio

(95% CI)

p-value

Odds ratio

(95% CI)

p-value

Sex

 M

1.00

 

1.00

 

 F

0.70 (0.34–1.44)

0.334

0.64 (0.32–1.27)

0.205

Age (yrs)

1.01 (0.98–1.04)

0.454

1.02 (0.99–1.05)

0.310

UP

 No

1.00

 

1.00

 

 Yes

1.11 (0.61–2.00)

0.738

1.43 (0.77–2.67)

0.262

UAs

 No

1.00

 

1.00

 

 Yes

1.17 (0.64–2.13)

0.614

0.99 (0.54–1.86)

0.995

UP + UAs

 No

1.00

 

1.00

 

 Yes

4.23 (1.57–11.4)

0.004

3.44 (1.42–8.31)

0.006

  1. UP Unilateral pain, UAs Unilateral cranial autonomic symptoms, Hosmer–Lemeshow test for different models ranged from χ2 = 1.800 to χ2 = 8.960, with corresponding p-values ranging from 0.987 to 0.346